Placebo News and Research

RSS

The connection between the Pope and contraceptive pills

Millions of women around the world use the combined hormonal oral contraceptive pill whcih has been around the past six decades. The usual method advised is a 21 day cycle of the pill followed by a 7 day break when the woman bleeds.

22 Jan 2019

Experimental drug can positively modify key characteristic behavior in FXS patients

Researchers at MIND Institute at UC Davis and Rush University Medical Center have found that mavoglurant, an experimental drug known as a mGluR5 negative modulator, can positively modify a key characteristic behavior in individuals with fragile X syndrome.

22 Jan 2019

Poo transplant can successfully treat patients with ulcerative colitis

Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.

16 Jan 2019

B-group vitamins may be beneficial for people with first episode psychosis

B-group vitamins may be beneficial for maintaining concentration skills among people experiencing a first episode of psychosis, a study by researchers from Orygen, the National Centre of Excellence in Youth Mental Health, has found.

16 Jan 2019

New class of sleeping pill preserves ability to wake in response to danger signals

In a trial of one of the main class of prescription sleeping pills, half the participants slept through a fire alarm as loud as someone vacuuming next to their bed. But a newer alternative preserves the ability to wake in response to danger signals, according to a new research.

11 Jan 2019

Researchers examine benefits of oral supplement for patients with thyroid eye disease

Fight for Sight and the Thyroid Eye Disease Charitable Trust are funding research to establish the benefits of using a type of oral supplement for UK patients with thyroid eye disease, which affects around 300,000 people in the UK.

11 Jan 2019

Genetic variations may influence whether vitamin E decreases or increases cancer risk

Almost half of all Americans take a vitamin supplement, and yet many large-scale, placebo-controlled clinical trials of various supplements have found little or no benefit.

8 Jan 2019

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

With more than 1.8 million children in the U.S. being treated annually with drugs for attention deficit hyperactivity disorder, the possibility that such drugs could damage their hearts has been a significant cause of concern for parents and physicians alike.

3 Jan 2019

Higher levels of nicotine may help quit smoking, research suggests

Allowing smokers to determine their nicotine intake while they are trying to quit is likely to help them kick the habit, according to an early study in 50 people led by Queen Mary University of London.

2 Jan 2019

Multicenter study demonstrates effectiveness, safety of topical antibiotics in NICU babies

A team of doctors led by Karen L. Kotloff, M.D., University of Maryland School of Medicine, Center for Vaccine Development and Global Health, has performed a clinical trial involving multiple hospitals that tested the effectiveness of applying a topical antibiotic known as mupirocin for prevention of Staphylococcus aureus infection in babies in the neonatal intensive care unit.

28 Dec 2018

How physical activity decreases belly fat in humans

Some of you may have made a New Year's resolution to hit the gym to tackle that annoying belly fat. But have you ever wondered how physical activity produces this desired effect? A signaling molecule called interleukin-6 plays a critical role in this process, researchers report December 27 in the journal Cell Metabolism.

28 Dec 2018

New vaccine shows promise against chikungunya virus

A live vaccine genetically engineered from a common measles vaccine promises to be effective against the chikungunya virus. Such is the central finding of a recently completed Phase II trial now published in the prestigious journal "The Lancet".

21 Dec 2018

GW researchers receive NIH funding to study causes of high risk of heart disease in HIV patients

Atherosclerosis and cardiovascular disease are major complications of HIV infection and cannot currently be treated by antiretroviral treatments.

21 Dec 2018

Researchers aim to improve cognition, reverse weight gain in schizophrenia

Aerobic exercise can improve the size and function of the brain, and now investigators want to know if it can also improve cognitive function in patients with schizophrenia who struggle with memory and attention problems.

19 Dec 2018

Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy

Heart and lung complications are responsible for much of the morbidity and mortality associated with Duchenne muscular dystrophy (DMD).

18 Dec 2018

New bacterial species may help fight obesity and metabolic disorders

The MyNewGut project has discovered new bacterial species and strains in healthy people that seem to be effective against obesity, metabolic and mental disorders related to stress and obesity (e.g. depression).

17 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Research offers hope for patients with serious bone marrow cancer

Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

14 Dec 2018

Magnesium may play important role in optimizing vitamin D levels, study shows

A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.

14 Dec 2018

Study highlights need for personalized approach to treat ICU acquired delirium

A population heath study from the Regenstrief Institute and Indiana University Center for Aging Research has determined that halo, did not benefit elective thoracic surgery ICU patients when given prophylactically, with the possible exception of those who have had surgery to remove their esophagus.

14 Dec 2018

Placebo News and Research

The connection between the Pope and contraceptive pills

Experimental drug can positively modify key characteristic behavior in FXS patients

Poo transplant can successfully treat patients with ulcerative colitis

B-group vitamins may be beneficial for people with first episode psychosis

New class of sleeping pill preserves ability to wake in response to danger signals

Researchers examine benefits of oral supplement for patients with thyroid eye disease

Genetic variations may influence whether vitamin E decreases or increases cancer risk

Commonly prescribed ADHD drug unlikely to increase cardiovascular risks in children

Higher levels of nicotine may help quit smoking, research suggests

Multicenter study demonstrates effectiveness, safety of topical antibiotics in NICU babies

How physical activity decreases belly fat in humans

New vaccine shows promise against chikungunya virus

GW researchers receive NIH funding to study causes of high risk of heart disease in HIV patients

Researchers aim to improve cognition, reverse weight gain in schizophrenia

Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy

New bacterial species may help fight obesity and metabolic disorders

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Research offers hope for patients with serious bone marrow cancer

Magnesium may play important role in optimizing vitamin D levels, study shows

Study highlights need for personalized approach to treat ICU acquired delirium

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News